Skandinaviska Enskilda Banken Ab (Publ) Sangamo Therapeutics, Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$10.17 - $12.64 $345,780 - $429,760	-34,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $169,728 - $265,980	-15,600 Reduced 31.45%	34,000 $426,000
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $465,248 - $619,008	49,600 New	49,600 $469,000

109

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.